Mayilvahanan Shanmugam Selected Research

sarcolipin

1/2014	Increased sarcolipin expression and adrenergic drive in humans with preserved left ventricular ejection fraction and chronic isolated mitral regurgitation.
12/2013	Increased sarcolipin expression and decreased sarco(endo)plasmic reticulum Ca2+ uptake in skeletal muscles of mouse models of Duchenne muscular dystrophy.
6/2012	Ablation of sarcolipin results in atrial remodeling.
6/2011	Decreased sarcolipin protein expression and enhanced sarco(endo)plasmic reticulum Ca2+ uptake in human atrial fibrillation.
2/2011	Ablation of phospholamban and sarcolipin results in cardiac hypertrophy and decreased cardiac contractility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mayilvahanan Shanmugam Research Topics

Disease

2	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2014 - 11/2013
2	Heart Failure 06/2011 - 02/2011
1	Wounds and Injuries (Trauma) 10/2017
1	Infections 01/2015
1	Bone Resorption 01/2015
1	Acute-Phase Reaction 01/2014
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2013
1	Fistula 11/2013
1	Fibrosis (Cirrhosis) 06/2012
1	Atrial Remodeling 06/2012
1	Atrial Fibrillation 06/2011
1	Cardiomegaly (Heart Hypertrophy) 02/2011
1	Neoplasms (Cancer) 01/2009
1	Melanoma (Melanoma, Malignant) 01/2009

Drug/Important Bio-Agent (IBA)

5	sarcolipinIBA 01/2014 - 02/2011
2	Adenosine Triphosphatases (ATPase)IBA 12/2013 - 02/2011
2	Proteins (Proteins, Gene)FDA Link 06/2011 - 01/2009
1	Prostaglandins AIBA 01/2015
1	GTP-Binding Proteins (G-Protein)IBA 01/2014
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2014
1	Xanthine OxidaseIBA 11/2013
1	Extracellular Matrix ProteinsIBA 06/2012
1	CollagenIBA 06/2012
1	Messenger RNA (mRNA)IBA 06/2011
1	phospholambanIBA 02/2011
1	Peptides (Polypeptides)IBA 01/2009
1	vpr Gene ProductsIBA 01/2009
1	Indicators and Reagents (Reagents)IBA 01/2009
1	Amino Acids FDA Link 01/2009

Therapy/Procedure

1	Debridement 10/2017
1	Therapeutics 01/2014